This event is run at arm's length from the financial supporters including Sanofi and all content was created by the faculty. No funder has had input into the content of the materials or presentations. CSL has provided funding towards this independent programme and has had no input into the agenda, speaker selection, or content of the event.

Event Schedule

Wednesday, May 6, 2026
9:30 AM - 9:40 AM
Chair's Opening Remarks
 
 
 
 
 
9:40 AM - 10:25 AM
Panel Discussion: Equity in immunisation and vaccines hesitancy
 
 
 
 
 
10:40 AM - 11:25 AM
The gonorrhea vaccine programme, what do we need to know in primary care?
  • Background and overview UK gonorrhea program (increasing incidence, increasing AMR, economic burden, prevention strategy) 
  • Disease overview (transmission, increase in asymptomatic infections, complications, AMR) 
  • The vaccine – what you need to know (mechanism, eligibility and risk groups) 
  • How primary care can help (identification and signposting, patient conversations, reducing inequalities) 
  • Q+A
 
 
 
 
11:40 AM - 12:25 PM
Routine seasonal vaccines: Selection and procurement - the importance of clinical differentiation and evaluating quality of evidence
  • How seasonal vaccinations programs are changing and the clinical and economic impact of vaccine selection
  • Clinical differentiation (key decision factors and practical scenarios) 
  • Evaluating quality of evidence (study design, interpreting endpoints, trusted evidence sources)
  • Procurement and practice level planning (forecasting and populations demographics, decision frameworks for selection, alignment with national guidance, supply/supplier 
  • considerations, scheduling and co-administration strategies) 
  • Q+A
 
 
 
 
12:40 PM - 1:25 PM
From flu to RSV, navigating the respiratory vaccine landscape
  • Epidemiology and burden of respiratory infections
  • Updates on influenza vaccines, RSV prevention (infants and children, older adults) and other respiratory immunisations 
  • Navigating the vaccine landscape in practice 
  • JCVI and guidance updates
  • Q+A 
 
 
 
 
1:40 PM - 2:25 PM
Travel vaccines: Emerging risks, vaccine-preventable diseases, and UK travel trends
  • Overview of current travel trends, increasing complexities of travel itineraries and seasonal patterns in travel clinic demand
  • Emerging risks (shifting patterns of mosquito‑borne diseases, outbreak‑prone diseases, climate‑driven changes in disease distribution and AMR hotspots)
  • What’s available and when to use (routine and specialists travel vaccinations)
  • The role of primary care in early risk assessment vaccination and patient education 
  • Q+A
 
 
 
 
2:40 PM - 3:25 PM
Beyond flu and COVID-19
  • Why this matters now (shifting burden of vaccine‑preventable diseases, missed opportunities in primary care) 
  • Pneumococcal disease: what primary care needs to know (inc. practical care considerations, identifying eligible patients, co-admin with other vaccine, complex cases, common 
  • misconceptions) 
  • Shingles: what primary care needs to know (inc. disease overview, epidemiology and overview national guidance, vaccination options, framing risk to patients) 
  • Q+A
     
 
 
 
 
3:40 PM - 4:25 PM
Chickenpox (Varicella) vaccine: what primary care needs to know
  • Disease overview (Varicella-zoster virus and transmission)
  • JCVI recommendations
  • Vaccination options (Varicella vaccines and schedules, Co-administration with MMR)
  • Addressing “mild disease” perceptions
  • Discussing complications and community protection
  • Q+A
     
 
 
 
 
4:25 PM - 4:35 PM
Closing remarks
 
 
 
 
 
4:35 PM
Conference ends
 
 
 
 
 

5.25 CPD hours